telogen effluvium semaglutide GLP-1 Hair Loss: How Wegovy, Ozempic & Mounjaro Cause Thinning (And Ho Semaglutide Hair Loss: What the

Proven Benefits For Cardiovsacular Risk Reduction In addition to promoting weight loss, semaglutide has been shown to provide a 20% relative risk reduction in major adverse cardiovascular events, such as heart attack and stroke, when added to standard cardiovascular care

Controlling cell death through post-translational modifications of DED proteins

When labs are ordered in GLP-1 treatment, providers typically look at markers that help evaluate metabolic function, organ health, and potential risk factors: A1C and fasting glucose: to assess baseline glycemic control [2] Kidney function: to monitor dehydration risk and fluid balance, which GLP-1-related gastrointestinal side effects can affect [3] Liver enzymes: to ensure safe medication clearance and dosing [4] Lipid panel: to track key cardiometabolic markers that often shift with weight loss [5] Thyroid panel: to rule out thyroid disorders that can contribute to weight changes or mimic weight-related symptoms [6] Complete blood count and electrolytes: to check for underlying health issues or imbalances that could complicate early treatment [7] Important: Because Peak Wellness relies primarily on intake-based evaluation, patients with known medical conditions or incomplete health histories may want to discuss whether additional testing would be beneficial before starting treatment

doi: 10.1093/AJCN/67.4.669 214

What the Long-Term Safety Picture Looks Like The existing Retatrutide safety data extends to 48 weeks